Schedule of Activity of Warrant (Details) - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||
| Number of Warrants Outstanding, Beginning | 5,380,661 | |
| Weighted Average Exercise Price, Beginning | $ 2.20 | |
| Average Life (years) Outstanding, beginning | 4 years 4 months 17 days | 4 years 6 months 7 days |
| Number of Warrants Outstanding, Beginning | 3,981,127 | 5,380,661 |
| Weighted Average Exercise Price, Beginning | $ 2.23 | $ 2.20 |
| Number of Warrants, Exercisable | 3,981,127 | |
| Weighted Average Exercise Price, Exercisable | $ 2.23 | |
| Average Life (years) Exercisable, End | 4 years 4 months 17 days | |
| 2.25 Exercise Price One [Member] | ||
| Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||
| Number of Warrants, Exercised | (1,399,534) | |
| Weighted Average Exercise Price, Exercised | $ 2.10 |
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options equity instruments exercisable. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, outstanding. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options exercises in period weighted average exercisable price. No definition available.
|
| X | ||||||||||
- Definition Share-based compensation arrangements by share-based payment award non-options exercises in period eighted average exercised price. No definition available.
|
| X | ||||||||||
- Definition Warrants, outstanding term. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangements by share based payment award non options outstanding in period exercisable. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|